Arrowhead Pharmaceuticals
ARWR
#1766
Rank
ยฃ9.05 B
Marketcap
ยฃ64.27
Share price
-1.36%
Change (1 day)
434.01%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2026 (TTM): ยฃ0.70

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is ยฃ0.61. In 2025 the company made an earnings per share (EPS) of -ยฃ0.007508 an increase over its 2024 EPS that were of -ยฃ3.75.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.70-9356.59%
2025-ยฃ0.007508-99.8%
2024-ยฃ3.75161.39%
2023-ยฃ1.4417.36%
2022-ยฃ1.2219.85%
2021-ยฃ1.0261.9%
2020-ยฃ0.63-216.67%
2019ยฃ0.54-210.77%
2018-ยฃ0.4938.3%
2017-ยฃ0.35-64.93%
2016-ยฃ1.01-16.25%
2015-ยฃ1.2028%
2014-ยฃ0.94-3.85%
2013-ยฃ0.98-31.58%
2012-ยฃ1.43331.82%
2011-ยฃ0.33-51.11%
2010-ยฃ0.68-79.07%
2009-ยฃ3.23-37.68%
2008-ยฃ5.18-16.87%
2007-ยฃ6.2338.33%
2006-ยฃ4.50122.22%
2005-ยฃ2.0342.11%
2004-ยฃ1.43533.33%
2003-ยฃ0.23-99.08%
2002-ยฃ24.3825%
2001-ยฃ19.5033.33%
2000-ยฃ14.63-120%
1999ยฃ73.13-400%
1998-ยฃ24.38-81.48%
1997-ยฃ131.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.56 978.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-ยฃ6.12-1,106.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ5.89 867.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.85 367.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-ยฃ1.70-380.25%๐Ÿ‡บ๐Ÿ‡ธ USA